POSSIBLE NIZATIDINE-INDUCED SUBFULMINANT HEPATIC-FAILURE

被引:2
作者
CHEY, WD [1 ]
KOCHMAN, ML [1 ]
TRABER, PG [1 ]
APPELMAN, HD [1 ]
GUMUCIO, JJ [1 ]
机构
[1] UNIV MICHIGAN,MED CTR,DEPT PATHOL,ANN ARBOR,MI 48109
关键词
NIZATIDINE; HISTAMINE-2 RECEPTOR ANTAGONIST; HEPATOTOXICITY; HEPATIC FAILURE; CIRRHOSIS;
D O I
10.1097/00004836-199503000-00022
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Subfulminant hepatic failure has not been reported to occur with the histamine-2 receptor antagonists. We report a possible case of nizatidine-induced subfulminant hepatic failure leading to the eventual development of cirrhosis.
引用
收藏
页码:164 / 167
页数:4
相关论文
共 11 条
[1]   FULMINANT AND SUBFULMINANT LIVER-FAILURE - DEFINITIONS AND CAUSES [J].
BERNUAU, J ;
RUEFF, B ;
BENHAMOU, JP .
SEMINARS IN LIVER DISEASE, 1986, 6 (02) :97-106
[2]   CIMETIDINE - REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFICACY IN PEPTIC-ULCER DISEASE [J].
BROGDEN, RN ;
HEEL, RC ;
SPEIGHT, TM ;
AVERY, GS .
DRUGS, 1978, 15 (02) :93-131
[4]  
FELDMAN M, 1990, NEW ENGL J MED, V323, P1672
[5]   RANITIDINE - AN UPDATED REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES AND THERAPEUTIC USE IN PEPTIC-ULCER DISEASE AND OTHER ALLIED DISEASES [J].
GRANT, SM ;
LANGTRY, HD ;
BROGDEN, RN .
DRUGS, 1989, 37 (06) :801-870
[6]  
JONES EA, 1990, HEPATOLOGY TXB LIVER, V1, P460
[7]  
KARVOUNTZIS GG, 1974, GASTROENTEROLOGY, V67, P870
[8]   FAMOTIDINE - AN UPDATED REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC USE IN PEPTIC-ULCER DISEASE AND OTHER ALLIED DISEASES [J].
LANGTRY, HD ;
GRANT, SM ;
GOA, KL .
DRUGS, 1989, 38 (04) :551-590
[9]  
LEWIS JH, 1987, AM J GASTROENTEROL, V82, P987
[10]   NIZATIDINE - A PRELIMINARY REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND ITS THERAPEUTIC USE IN PEPTIC-ULCER DISEASE [J].
PRICE, AH ;
BROGDEN, RN .
DRUGS, 1988, 36 (05) :521-539